{"id":5831,"date":"1998-07-28T10:28:00","date_gmt":"1998-07-28T10:28:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5831"},"modified":"2021-07-28T10:30:51","modified_gmt":"2021-07-28T10:30:51","slug":"granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/","title":{"rendered":"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Rembacken%2C+BJ\">B.J. Rembacken<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Newbould%2C+HE\">H.E. Newbould<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Richards%2C+SJ\">S.J. Richards<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Misbah%2C+SA\">S.A. Misbah<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Dixon%2C+ME\">M.E. Dixon<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Chalmers%2C+DM\">D.M. Chalmers<\/a>,\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/action\/doSearch?ContribAuthorStored=Axon%2C+ATR\">A.T.R. Axon<\/a>, <a href=\"https:\/\/doi.org\/10.1111\/j.1744-9987.1998.tb00082.x\">https:\/\/doi.org\/10.1111\/j.1744-9987.1998.tb00082.x<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>We have studied the effects of granulocyte apheresis in 18 patients with ulcerative colitis and 6 with Crohn&#8217;s disease who had failed to respond to conventional therapy. Patients were treated with weekly apheresis using a granulocyte removal column (GI, Otsuka Pharmaceutical Co., Ltd., London, U.K.). We found a mean reduction in circulating granulocytes of 1.29 \u00d7 10<sup>9<\/sup>\u00a0cells\/L with no significant alterations in red blood cell monocyte, total lymphocyte, absolute T-helper, or T-cytotoxic lymphocyte counts. There were no significant changes in complement levels or immunoglobulin subclasses. There was a signifycant increase in granulocyte adhesion and a reduction in L-selectin expression. The removal of granulocytes is unlikely to explain the effect of granulocytapheresis. The markedly increased expression of \u03b1<sub>m<\/sub>\u00a0integrin\/Mac-1 and low L-selectin expression alter the capability of granulocytes to migrate to sites of inflammation and may be responsible for the improvement observed in patients treated with granulocyte apheresis.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/j.1744-9987.1998.tb00082.x\">Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect &#8211; Rembacken &#8211; 1998 &#8211; Therapeutic Apheresis &#8211; Wiley Online Library<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>B.J. Rembacken,\u00a0H.E. Newbould,\u00a0S.J. Richards,\u00a0S.A. Misbah,\u00a0M.E. Dixon,\u00a0D.M. Chalmers,\u00a0A.T.R. Axon, https:\/\/doi.org\/10.1111\/j.1744-9987.1998.tb00082.x We have studied the effects of granulocyte apheresis in 18 patients with ulcerative colitis and 6 with Crohn&#8217;s disease who had failed to respond to conventional therapy. Patients were treated with weekly apheresis using a granulocyte removal column (GI, Otsuka Pharmaceutical Co., Ltd., London, U.K.). We [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[],"class_list":["post-5831","scientific-corner","type-scientific-corner","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte\" \/>\n<meta property=\"og:description\" content=\"B.J. Rembacken,\u00a0H.E. Newbould,\u00a0S.J. Richards,\u00a0S.A. Misbah,\u00a0M.E. Dixon,\u00a0D.M. Chalmers,\u00a0A.T.R. Axon, https:\/\/doi.org\/10.1111\/j.1744-9987.1998.tb00082.x We have studied the effects of granulocyte apheresis in 18 patients with ulcerative colitis and 6 with Crohn&#8217;s disease who had failed to respond to conventional therapy. Patients were treated with weekly apheresis using a granulocyte removal column (GI, Otsuka Pharmaceutical Co., Ltd., London, U.K.). We [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-28T10:30:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/\",\"name\":\"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"1998-07-28T10:28:00+00:00\",\"dateModified\":\"2021-07-28T10:30:51+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/","og_locale":"es_ES","og_type":"article","og_title":"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte","og_description":"B.J. Rembacken,\u00a0H.E. Newbould,\u00a0S.J. Richards,\u00a0S.A. Misbah,\u00a0M.E. Dixon,\u00a0D.M. Chalmers,\u00a0A.T.R. Axon, https:\/\/doi.org\/10.1111\/j.1744-9987.1998.tb00082.x We have studied the effects of granulocyte apheresis in 18 patients with ulcerative colitis and 6 with Crohn&#8217;s disease who had failed to respond to conventional therapy. Patients were treated with weekly apheresis using a granulocyte removal column (GI, Otsuka Pharmaceutical Co., Ltd., London, U.K.). We [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/","og_site_name":"Adacyte","article_modified_time":"2021-07-28T10:30:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/","name":"Granulocyte Apheresis in Inflammatory Bowel Disease: Possible Mechanisms of Effect - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"1998-07-28T10:28:00+00:00","dateModified":"2021-07-28T10:30:51+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-apheresis-in-inflammatory-bowel-disease-possible-mechanisms-of-effect\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5831"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}